Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease

Intravenous administration of gadolinium-based contrast agents (GBCA) in patients with impaired renal function has been of concern to primary care physicians due to the potential worsening of renal dysfunction and nephrogenic systemic fibrosis (NSF). Our objective was to compare the potential change in estimated glomerular filtration rate (eGFR) in patients with known severe renal dysfunction (eGFR
Source: Clinical Imaging - Category: Radiology Authors: Tags: Body Imaging Source Type: research